Aspirin for heart disease patients in polluted air
Part of Brain & nervous system, Digestive system, Heart & circulation clinical trials.
This study tests if different types of aspirin (coated or chewable) and a special schedule can help people with heart or blood vessel disease when they are exposed to air pollution. If you live in Tehran and have stable heart disease, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a documented heart or blood vessel condition, like a past heart attack, a stent or bypass surgery, blocked leg arteries, or a prior stroke not caused by an irregular heartbeat
- You live in Tehran province
- You are willing to take aspirin as part of your regular treatment and can receive text messages or phone calls
- You have not had a serious bleeding event (stomach or brain) in the last 30 days, and you do not have advanced kidney disease or a short life expectancy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether daily aspirin is safe and effective for people who have stable (chronic) coronary artery disease but cannot have procedures to open blocked arteries. It may help reduce future heart problems, while also checking for side effects and risks from aspirin.
This trial tests whether taking aspirin can help people who have early signs of coronary artery disease (buildup in heart arteries) but have never had a heart attack or stroke. The goal is to see if aspirin prevents future heart problems in these patients.
This study looks at how blood-thinning medications (like aspirin and clopidogrel) work in people with hardened arteries or peripheral artery disease (PAD). By understanding this, doctors hope to improve treatment and prevent heart attacks and strokes.
This trial tests whether older adults with stable heart disease can safely stop taking daily aspirin after two years without increasing the risk of heart attack or stroke. It may help reduce the side effects of long-term aspirin use.
This trial compares two common “blood thinner” combinations to prevent problems after a PCI procedure for complex blocked heart arteries. It may help your care team find which combination works better for people with higher-risk artery patterns.
This trial tests whether adding a special scan to look at the fatty plaque in your arteries can help your doctor decide if you need stronger heart medication to prevent future heart attacks or strokes. If you have moderate blockages and signs of inflammation, you may be able to join.
Hear when a new Atherosclerotic Cardiovascular Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.